Alternatively, CYP26A1 overexpression might be directly associated with the cumulative alterations of aberrant signaling, including activation of proto-oncogenes and inactivation of multiple tumor suppressor genes [12]. This evidence concerns the gene CYP26A1 and neoplasm.